While eight out of the nine studies included in this meta-analysis detected a statistically significant increase or decrease in serum levels of IGF-1 in Alzheimer’s disease subjects, the analysis as a whole did not show a significant trend in either direction. The gene discussed is IGF1; the disease is early-onset autosomal dominant Alzheimer disease.